WK Kellogg Co Announces First Quarter 2025 Results and Updates 2025 Outlook
BATTLE CREEK, Mich., May 6, 2025 /PRNewswire/ -- WK Kellogg Co (NYSE: KLG), today reported financial results for its first quarter 2025 and updated its full year 2025 financial outlook.
WKKC Logo (PRNewsfoto/WK Kellogg Co)
All documents will be posted to the company website including: the financial press release and tables, GAAP reconciliations, presentation slides, pre-recorded management remarks, and transcript at https://investor.wkkellogg.com/news-events/events-and-presentations/default.aspx.
A Current Report on Form 8-K was furnished with the U.S. Securities and Exchange Commission and is available on its website at www.sec.gov.
WK Kellogg Co will host a live webcast question and answer session with analysts, to discuss its first quarter 2025 on Tuesday, May 6, 2025, at 10:00 a.m. Eastern Time. The Q&A call will be webcast live over the Internet at http://investor.wkkellogg.com. Information regarding the rebroadcast is available at http://investor.wkkellogg.com.
About WK Kellogg Co
At WK Kellogg Co, we bring our best to everyone, every day through our trusted foods and brands. Our journey began in 1894, when our founder W.K. Kellogg reimagined the future of food with the creation of Corn Flakes, changing breakfast forever. Our iconic brand portfolio includes Kellogg's Frosted Flakes®, Rice Krispies®, Froot Loops®, Kashi®, Special K®, Kellogg's Raisin Bran®, and Bear Naked®. With a presence in the majority of households across North America, our brands play a key role in enhancing the lives of millions of consumers every day, promoting a strong sense of physical, emotional and societal wellbeing. Our beloved brand characters, including Tony the Tiger® and Toucan Sam®, represent our deep connections with the consumers and communities we serve. Through our sustainable business strategy – Feeding Happiness™ – we aim to build healthier and happier futures for families, kids and communities. We are making a positive impact, while creating foods that bring joy and nourishment to consumers. For more information about WK Kellogg Co and Feeding Happiness, visit www.wkkellogg.com.
Cision
View original content to download multimedia:https://www.prnewswire.com/news-releases/wk-kellogg-co-announces-first-quarter-2025-results-and-updates-2025-outlook-302446900.html
SOURCE WK Kellogg Co
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 minutes ago
- Yahoo
IQVIA Holdings (NYSE:IQV) Sees 11% Share Price Rise Over Last Week
IQVIA Holdings experienced a 10% rise in share price over the last week, correlating with its recent developments, notably the dosing of the first patient in the RENEW Phase 2 trial and its strategic alliance with Sarah Cannon Research Institute to optimize oncology trials. These initiatives likely provided a positive sentiment boost, aligning well with the broader market momentum, as indices such as the S&P 500 also reached new highs. The market's anticipation over US-China trade talks and overall strong corporate earnings have supported the upward trend, further enhancing IQV's market performance. We've identified 1 warning sign for IQVIA Holdings that you should be aware of. Uncover 18 companies that survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. The recent 10% rise in IQVIA Holdings' share price has been influenced by important developments like the dosing in the RENEW Phase 2 trial and a key alliance with Sarah Cannon Research Institute. These initiatives are expected to potentially drive revenue growth, particularly as the strategic alliance optimizes oncology trials. The company's past performance, with total returns of 10.45% over five years, suggests modest growth in investor value. However, compared to the US Life Sciences industry's one-year return of 27% decline, IQVIA's recent rise highlights positive market sentiment. These initiatives, combined with FDA reforms and NVIDIA collaboration, may lower operational costs and have a favorable impact on earnings forecasts. Analysts predict revenue to grow by 5.2% annually over the next three years, which is somewhat cautious compared to the general expectations for the life sciences sector. The recent share price movement to US$146.2 remains below the consensus price target of US$216.31, indicating potential for future appreciation if the projected growth in revenue and earnings materializes. Click here to discover the nuances of IQVIA Holdings with our detailed analytical financial health report. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:IQV. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
12 minutes ago
- Yahoo
New IBO Survey Reveals Major Cuts to Lab Budgets Amid NIH Grant Terminations
ARLINGTON, Va., June 10, 2025 /PRNewswire/ -- A new survey conducted by Instrument Business Outlook (IBO) has uncovered significant reductions in laboratory budgets across the U.S. academic and government research landscape, with lab product spending sharply impacted by recent NIH grant terminations. The findings, based on an exclusive IBO survey, shed light on the growing financial uncertainty facing scientific research labs in 2025. The results follow widespread disruptions in NIH funding, with more than 1,500 grants totaling $7.5 billion terminated as of May 20, according to data from Grant Watch. While the exact numbers remain fluid due to inconsistent reporting by federal agencies, the toll is undeniable: R01 research grants—a cornerstone of basic research—have been particularly hard-hit, with 322 grants worth nearly $790 million terminated. "The fallout from NIH funding changes is cascading through the research ecosystem," said Tanya Samazan, Editor-In-Chief. "Our survey shows just how deeply this uncertainty is affecting labs—from basic research to clinical trial infrastructure." Survey Highlights: Budget Cuts Across the Board Conducted by the Science Advisory Board (SAB) between mid- and late May, the survey collected 117 responses from U.S.-based labs, with 88 indicating their labs were impacted by NIH-related funding disruptions. Key findings include: 59% of labs report direct impacts from NIH-related grant or contract terminations, delays, or reductions. 47% report indirect impacts. Among affected labs, nearly 60% have reduced 2025 operating budgets by more than 10%. 51% report capital budget reductions exceeding 10%. When excluding labs that were uncertain or unaffected, the scale becomes even more dramatic: 71% of labs report operating budget cuts of over 10%. 71% report similar reductions in capital budgets. Lab Tools and Consumables Hit Hardest Every category of lab spending has been affected, according to survey data: 80% of labs have reduced their 2025 consumables budgets, making it the most impacted category. 63% have cut software/informatics budgets. 70% have reduced spending on devices under $50,000. Even high-end instrumentation (>$150,000) hasn't been spared, with 62% of labs trimming these budgets. Institutes Most Affected The survey findings align with NIH grant termination data indicating the hardest-hit institutions include: National Institute of Mental Health, with over $400 million in losses. National Institute of General Medical Sciences, which lost the highest number of grants (134). Institutes heavily reliant on lab instruments, including the National Institute of Biomedical Imaging and Bioengineering and the National Human Genome Research Institute. Medical schools and hospitals have borne a significant share of the burden, accounting for 50% of terminated grants and 55% of total terminated NIH dollars. A Shifting Landscape with No Clear Path Forward The rapidly evolving nature of NIH decisions—including ongoing terminations and reinstatements—has created a volatile funding environment. Labs are being forced to make difficult decisions with limited visibility into future funding. About Instrument Business Outlook (IBO)IBO is a leading newsletter providing market intelligence for the analytical instrument industry. Published by Strategic Directions International (SDi), a division of Science and Medicine Group, IBO offers in-depth coverage of technology, business, and market trends affecting the life sciences and lab tools sectors. View original content to download multimedia: SOURCE Instrument Business Outlook
Yahoo
17 minutes ago
- Yahoo
Toll Brothers Announces New Regency 55+ Active-Adult Homes are Now Open for Sale in Chambers Creek Master Plan in Willis, Texas
WILLIS, Texas, June 10, 2025 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, today announced that its new Regency 55+ active-adult home designs are now open for sale within the Chambers Creek master plan by Caldwell Communities, located just north of Houston in Willis, Texas. These new luxury single-level homes designs are the first Regency active adult offering from Toll Brothers in the Houston area. The Toll Brothers Regency Sales Center and model home are now open in Chambers Creek at 9835 Vista Ridge Circle in Willis, Texas. The sophisticated new Toll Brothers Regency homes showcase convenient single-level living and modern open floor plans ideal for entertaining. The Blossom Collection and Riverside Collection offer open concept home designs on 45- and 70-foot-wide home sites, respectively, with 2 to 3 bedrooms, up to 3.5 bathrooms, and private 2- and 3-car garages. Homes are priced from the upper $300,000s. Toll Brothers customers will experience one-stop shopping at the Toll Brothers Design Studio. The state-of-the-art Design Studio allows customers to choose from a wide array of selections to personalize their dream home with the assistance of Toll Brothers professional Design Consultants. Quick move-in homes with Designer Appointed Features will also be available at the community.'We are excited to open our first Regency home designs in the Houston area, offering 55+ home shoppers an unparalleled opportunity to enjoy an active lifestyle in this beautiful, amenity-rich community,' said Brian Murray, Division President of Toll Brothers in Houston. 'The Toll Brothers Regency homes offered in Chambers Creek feature the perfect mix of luxury and lifestyle, with stunning new single-level home designs and endless opportunities to enjoy life in the beautiful rolling hills just north of Houston.' Chambers Creek has been recognized as one of the Top Communities in the Nation for 2025 by the Private Communities Registry, highlighting its exceptional lifestyle and amenities. Chambers Creek offers an array of resort-style master plan amenities including a resort-style pool, a private boat launch with reserved boat slips, a vineyard, a community garden, a nine-hole Tom Lehman golf course, an 18-hole putting course, pickleball and tennis courts, and extensive parks and nature trails. In addition, the community boasts an exclusive gated setting including controlled access with an attendant and a full-time Lifestyle Director to plan community events. Chambers Creek residents also enjoy convenient access to entertainment, live music, fine dining, and shopping in nearby Conroe and The Woodlands, as well as Interstate 45 and George Bush Intercontinental Airport. Toll Brothers Regency active-adult homes and communities across the country are designed with the active lifestyles of their residents in mind, offering thoughtfully crafted homes tailored to residents aged 55 and older and access to resort-style amenities and social events that foster community engagement. For more information on the Regency home designs offered in Chambers Creek, Toll Brothers home shoppers are invited to call 833-289-8655 or visit About Toll Brothers Toll Brothers, Inc., a Fortune 500 Company, is the nation's leading builder of luxury homes. The Company was founded 58 years ago in 1967 and became a public company in 1986. Its common stock is listed on the New York Stock Exchange under the symbol 'TOL.' The Company serves first-time, move-up, empty-nester, active-adult, and second-home buyers, as well as urban and suburban renters. Toll Brothers builds in over 60 markets in 24 states: Arizona, California, Colorado, Connecticut, Delaware, Florida, Georgia, Idaho, Indiana, Maryland, Massachusetts, Michigan, Nevada, New Jersey, New York, North Carolina, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Virginia, and Washington, as well as in the District of Columbia. The Company operates its own architectural, engineering, mortgage, title, land development, smart home technology, and landscape subsidiaries. The Company also develops master-planned and golf course communities as well as operates its own lumber distribution, house component assembly, and manufacturing operations. Toll Brothers has been one of Fortune magazine's World's Most Admired Companies™ for 10+ years in a row, and in 2024 the Company's Chairman and CEO Douglas C. Yearley, Jr. was named one of 25 Top CEOs by Barron's magazine. Toll Brothers has also been named Builder of the Year by Builder magazine and is the first two-time recipient of Builder of the Year from Professional Builder magazine. For more information visit From Fortune, ©2025 Fortune Media IP Limited. All rights reserved. Used under license. Contact: Andrea Meck | Toll Brothers, Senior Director, Public Relations & Social Media | 215-938-8169 | ameck@ A photo accompanying this announcement is available at Sent by Toll Brothers via Regional Globe Newswire (TOLL-REG)Sign in to access your portfolio
